Insulet Corp (PODD)
164.49
-1.76
(-1.06%)
USD |
NASDAQ |
Apr 22, 16:00
164.50
+0.01
(+0.01%)
After-Hours: 20:00
Insulet Free Cash Flow (Quarterly): 13.60M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 13.60M |
September 30, 2023 | 33.60M |
June 30, 2023 | 25.90M |
March 31, 2023 | -36.60M |
December 31, 2022 | -37.70M |
September 30, 2022 | 22.80M |
June 30, 2022 | 6.20M |
March 31, 2022 | -29.60M |
December 31, 2021 | -62.40M |
September 30, 2021 | -55.00M |
June 30, 2021 | -4.90M |
March 31, 2021 | -68.50M |
December 31, 2020 | -70.70M |
September 30, 2020 | 17.60M |
June 30, 2020 | 1.60M |
March 31, 2020 | -31.00M |
December 31, 2019 | -3.00M |
September 30, 2019 | 7.00M |
June 30, 2019 | -37.70M |
March 31, 2019 | -38.80M |
December 31, 2018 | -4.401M |
September 30, 2018 | -21.77M |
June 30, 2018 | -60.69M |
March 31, 2018 | -39.64M |
December 31, 2017 | -7.494M |
Date | Value |
---|---|
September 30, 2017 | 14.53M |
June 30, 2017 | 4.575M |
March 31, 2017 | -47.51M |
December 31, 2016 | 17.16M |
September 30, 2016 | -10.62M |
June 30, 2016 | 0.936M |
March 31, 2016 | -13.68M |
December 31, 2015 | -22.08M |
September 30, 2015 | 6.221M |
June 30, 2015 | 0.53M |
March 31, 2015 | -7.834M |
December 31, 2014 | 1.974M |
September 30, 2014 | 1.714M |
June 30, 2014 | -3.08M |
March 31, 2014 | -3.174M |
December 31, 2013 | -6.308M |
September 30, 2013 | 1.872M |
June 30, 2013 | 2.746M |
March 31, 2013 | -2.269M |
December 31, 2012 | -7.648M |
September 30, 2012 | -8.136M |
June 30, 2012 | -13.66M |
March 31, 2012 | -10.60M |
December 31, 2011 | -9.944M |
September 30, 2011 | -4.114M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-70.70M
Minimum
Dec 2020
33.60M
Maximum
Sep 2023
-16.25M
Average
-4.90M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
Abbott Laboratories | 2.283B |
Stryker Corp | 1.383B |
Becton Dickinson & Co | 725.00M |
Haemonetics Corp | -22.83M |
Tandem Diabetes Care Inc | -34.70M |